Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study

  • C. R. Rowan
  • , D. Keegan
  • , K. Byrne
  • , G. Cullen
  • , H. E. Mulcahy
  • , J. Sheridan
  • , E. J. Ryan
  • , A. de Vries
  • , G. D'Haens
  • , G. A. Doherty

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science